Seton Hall University School of Law J.D., Concentration in Intellectual Property University of North Carolina at Chapel Hill B.S., Biomaterials
Oncology Endorsed by 6 colleagues at The Janssen Pharmaceutical Companies of Johnson & Johnson Endorsed by 9 people who know the skill 24 endorsements Clinical Operations 3 endorsements
Therapy Area Head: CKAD Novo Nordisk · Full-time Nov 2023 to Present · 1 yr 3 mos Senior Director, Head of Feasibility Center of Excellence The Janssen Pharmaceutical Companies of Johnson & Johnson Jul 2021 to Nov 2023 · 2 yrs 5 mos Johnson & Johnson 14 yrs 4 mos Global Feasibility TA Head, Oncology Mar 2019 to Jul 2021 · 2 yrs 5 mos Director, Strategic Account Lead Oct 2016 to Mar 2019 · 2 yrs 6 mos Associate Director, TCSM Oncology Oct 2010 to Oct 2016 · 6 yrs 1 mo Clinical Operations Associate Roche 2004 to 2007 · 3 yrs
米国の採用ディレクターの視点からAI分析 — キャリアの継続性、成長軌道、および役職適合性を評価します。
There is a public gap from Roche (2004-2007) to the next listed role (2010) of approximately 3 years. A brief explanation or documentation would help clarify uninterrupted career progression.
All roles are within pharma/biotech (Roche, Janssen/Johnson & Johnson, Novo Nordisk), indicating strong industry alignment and reducing onboarding risk in global pharma environments.
Demonstrated long tenures with progressive responsibilities at Janssen (2010-2023) and a subsequent move to Novo Nordisk; overall stability is strong.
Education from Seton Hall University School of Law is not a direct clinical operations credential; it may add governance/regulatory value but is not a typical operational qualification.
Demonstrated global leadership across oncology operations and feasibility with P&L oversight and cross-functional governance; aligns with her track record of multi-site leadership and strategic operational delivery.
Previous role as Head of Feasibility CoE and Global Feasibility TA Head; strong fit for leading the global feasibility function in a pharma/biotech setting.
Past experience in TCSM and strategic accounts, with progressive leadership; suited for a strategy-focused global ops executive role.
Broad operations leadership with oncology focus, capable of shaping end-to-end operations, scaling capabilities, and cross-functional performance.
Continuity in therapy-area leadership at a top pharma; valuable for organizations seeking a proven oncologic therapy leader with global exposure.
類似のスキルと背景を持つ候補者をさらに見つけられるグループとイベント。


AI駆動の採用ソリューションを活用して、採用プロセスを自動化し、時間コストの80%を削減している10,000社以上の企業に加わりましょう。
24時間365日自動運用
AIを活用した候補者スクリーニング
地理的・時差の制限なく採用活動
パーソナライズされたインテリジェントコミュニケーション
候補者エンゲージメントの自動評価
あなたの採用スタイルをインテリジェントに模倣・再現
4ヶ月間の返金保証
LinkedInアカウントのセキュリティを確保